Published in J Hepatol on June 30, 2010
Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med (2014) 1.71
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
Parent perspectives on decisions to participate in a phase I hepatocyte transplant trial. Pediatr Transplant (2013) 1.46
Magnetic cell labeling of primary and stem cell-derived pig hepatocytes for MRI-based cell tracking of hepatocyte transplantation. PLoS One (2015) 1.40
Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest (2012) 1.22
Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol (2011) 1.22
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation. Tissue Eng Part A (2012) 1.05
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World J Hepatol (2015) 1.01
Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells. Stem Cells Dev (2013) 0.93
Single liver lobe repopulation with wildtype hepatocytes using regional hepatic irradiation cures jaundice in Gunn rats. PLoS One (2012) 0.86
Cellular therapy and bioartificial approaches to liver replacement. Curr Opin Organ Transplant (2012) 0.86
Human hepatic progenitor cells express hematopoietic cell markers CD45 and CD109. Int J Med Sci (2013) 0.84
Monitoring of Liver Cell Transplantation in a Preclinical Swine Model Using Magnetic Resonance Imaging. Cell Med (2010) 0.84
Assembly of human organs from stem cells to study liver disease. Am J Pathol (2013) 0.83
Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells (2015) 0.80
Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts. PLoS One (2015) 0.80
Use of Magnetocapsules for In Vivo Visualization and Enhanced Survival of Xenogeneic HepG2 Cell Transplants. Cell Med (2012) 0.80
In vitro culture of functionally active buffalo hepatocytes isolated by using a simplified manual perfusion method. PLoS One (2015) 0.79
Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2014) 0.78
Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies. BMC Vet Res (2014) 0.78
The road to regenerative liver therapies: the triumphs, trials and tribulations. Biotechnol Adv (2013) 0.78
New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases. Curr Transplant Rep (2015) 0.77
Liver-Regenerative Transplantation: Regrow and Reset. Am J Transplant (2016) 0.77
Hepatocyte culture in autologous decellularized spleen matrix. Organogenesis (2015) 0.77
In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model. PLoS One (2015) 0.76
Generation of functional hepatocytes from human spermatogonial stem cells. Oncotarget (2016) 0.76
Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells. Mol Ther Nucleic Acids (2016) 0.76
A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Virol J (2016) 0.75
Improvement of Infusion Process in Cell Transplantation: Effect of Shear Stress on Hepatocyte Viability Under Horizontal and Vertical Syringe Orientation. Cell Med (2014) 0.75
Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro. Cell Med (2012) 0.75
Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer. Tissue Eng Part A (2016) 0.75
Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro. Stem Cells Dev (2014) 0.75
Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol (2016) 0.75
Hepatocyte Transplantation. Gastroenterol Hepatol (N Y) (2014) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology (2010) 6.40
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49
Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys (1995) 3.20
The extracellular matrix as a biologic scaffold material. Biomaterials (2007) 3.18
Replacement of diseased mouse liver by hepatic cell transplantation. Science (1994) 3.18
Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol (1997) 3.15
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A (2004) 2.54
Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A (1991) 2.19
Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology (2006) 2.04
Hepatocyte transplantation in acute liver failure. Liver Transpl (2000) 2.02
Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol (2004) 2.01
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet (2002) 1.86
Partial volume tolerance of the liver to radiation. Semin Radiat Oncol (2005) 1.85
Experimental models of hepatic fibrosis: a review. Semin Liver Dis (1990) 1.81
Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation (1997) 1.67
Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 1.64
One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62
Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science (1986) 1.61
Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology (1992) 1.60
Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis (1999) 1.57
Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation (1994) 1.54
Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat Med (1997) 1.53
Hepatocyte transplantation. J Hepatol (2004) 1.50
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride. Transplantation (2002) 1.48
Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res (1999) 1.39
Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35
Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation (2003) 1.31
New directions for organ transplantation. Nature (1998) 1.27
Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology (2000) 1.26
Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology (2009) 1.23
Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev (2000) 1.18
Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18
Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology (2000) 1.17
Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology (2002) 1.17
Animal models of fulminant hepatic failure. Dig Dis Sci (1991) 1.17
Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer Semin Immunopathol (1997) 1.16
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10
Hepatocyte transplantation. Transplantation (2004) 1.09
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest (1998) 1.03
Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl (2000) 1.01
A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics. Cryobiology (1993) 1.00
One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation (2009) 0.99
Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation. Radiology (1979) 0.98
Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation (2000) 0.96
Hepatocyte transplantation in man. Transplant Proc (1992) 0.95
Route of hepatocyte delivery affects hepatocyte engraftment in the spleen. Transplantation (2003) 0.94
Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates. Hepatology (2009) 0.92
Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology (1996) 0.92
Cryopreservation-induced nonattachment of human hepatocytes: role of adhesion molecules. Cell Transplant (2007) 0.91
Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias. Am J Nephrol (2005) 0.90
Human hepatocyte transplantation overview. Methods Mol Biol (2009) 0.90
Functional hepatocyte culture and its application to cell therapies. Cell Transplant (2006) 0.89
Peritoneal transplantation of human fetal hepatocytes for the treatment of acute fatty liver of pregnancy: a case report. Trop Gastroenterol (2005) 0.89
When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl (2004) 0.88
Hepatocellular transplantation for experimental ischemic acute liver failure in dogs. J Surg Res (1980) 0.87
Liver support technology--an update. Xenotransplantation (2006) 0.86
Hepatocellular carcinoma as second malignant neoplasms in successfully treated Wilms' tumor patients. A National Wilms' Tumor Study report. Cancer (1991) 0.86
Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation (1990) 0.85
Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer. J Clin Invest (2002) 0.85
Histidinemia in mice: a metabolic defect treated using a novel approach to hepatocellular transplantation. Hepatology (1995) 0.85
Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model. Transplantation (1996) 0.84
Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival. J Heart Lung Transplant (1992) 0.84
Update on liver transplantation: indications, organ allocation, and long-term care. Mt Sinai J Med (2006) 0.83
Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis (2001) 0.83
Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation (1996) 0.82
Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure. Surgery (1997) 0.81
Biomedicine. New genetic tricks to rejuvenate ailing livers. Science (2000) 0.80
Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis. Cell Transplant (2004) 0.80
Toward the survival and function of xenogeneic hepatocyte grafts. Liver Transpl (2005) 0.79
Reduction of anti-Galalpha1,3Gal antibodies by infusion of types 2 and 6 gal trisaccharides conjugated to poly-L-lysine. Xenotransplantation (2004) 0.78
Detection of albumin synthesis in transplanted porcine hepatocytes in mice. Liver Transpl (2002) 0.77
Genetic modification of xenografts. Curr Top Microbiol Immunol (2003) 0.77
Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med (2002) 18.61
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA (2010) 5.77
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol (2009) 5.69
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (2007) 3.39
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 3.32
A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr (2006) 3.32
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02
Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology (2004) 2.28
Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene (2003) 2.27
Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) (2010) 2.23
Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol (2006) 2.21
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol (2004) 2.09
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06
Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology (2006) 2.04
Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice. PLoS Genet (2005) 2.03
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. J Pediatr Gastroenterol Nutr (2015) 1.98
Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology (2008) 1.95
Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology (2008) 1.93
Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med (2004) 1.92
The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology (2008) 1.90
Biological implications of cell fusion. Nat Rev Mol Cell Biol (2005) 1.87
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet (2003) 1.85
Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (2013) 1.80
Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology (2013) 1.78
Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad Sci U S A (2013) 1.70
Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology (2007) 1.68
Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice. J Hepatol (2009) 1.64
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol (2004) 1.62
Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem (2002) 1.60
Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology (2005) 1.60
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60
Resetting the transcription factor network reverses terminal chronic hepatic failure. J Clin Invest (2015) 1.58
Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr (2002) 1.56
Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res (2002) 1.56
Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J (2008) 1.56
Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One (2009) 1.55
Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. Proc Natl Acad Sci U S A (2006) 1.53
Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A (2010) 1.50
Parents and clinicians underestimate distress and depression in children who had a transplant. Pediatr Transplant (2005) 1.50
Hepatocyte transplantation. J Hepatol (2004) 1.50
Effects of radiation on the epidermal growth factor receptor pathway in the heart. Int J Radiat Biol (2013) 1.49
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49
New technologies for organ replacement and augmentation. Mayo Clin Proc (2005) 1.48
Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev (2006) 1.48
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol (2003) 1.47
Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat. J Hepatol (2008) 1.47
Xenotransplantation and the future of renal replacement. J Am Soc Nephrol (2004) 1.47
A transition state analogue of 5'-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers. J Biol Chem (2007) 1.47
Resolution of hepatopulmonary syndrome after auxiliary partial orthotopic liver transplantation in Abernethy malformation. A case report. Liver Transpl (2007) 1.46
Parent perspectives on decisions to participate in a phase I hepatocyte transplant trial. Pediatr Transplant (2013) 1.46
Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol (2007) 1.46
Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol (2005) 1.45
Neonatal acute liver failure complicated by patent ductus venosus: diagnosis and management. Liver Transpl (2013) 1.45
Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics (2004) 1.44
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids. J Biol Chem (2005) 1.44
Liver transplantation for children with biliary atresia in the pediatric end-stage liver disease era: the role of insurance status. Liver Transpl (2013) 1.42
Conditional signaling by Toll-like receptor 4. FASEB J (2005) 1.42
Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology (2004) 1.41
Possible Phenylacetate Hepatotoxicity During 4-Phenylbutyrate Therapy of Byler Disease. J Pediatr Gastroenterol Nutr (2016) 1.41
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther (2002) 1.39
Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis. Pediatr Transplant (2004) 1.39
Primary sclerosing cholangitis: summary of a workshop. Hepatology (2006) 1.38
Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges. Oncology (Williston Park) (2008) 1.38
A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet (2004) 1.38
Immunosuppression by embryonic stem cells. Stem Cells (2007) 1.38
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology (2004) 1.36
Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation. Mol Genet Metab (2005) 1.33
The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry (2010) 1.32
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Frequent aneuploidy among normal human hepatocytes. Gastroenterology (2011) 1.30
Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. J Biol Chem (2010) 1.29
Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol (2007) 1.29